Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1992 Nov;51(5):943–950.

Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

C R Scriver, T M Fujiwara
PMCID: PMC1682854  PMID: 1384327

Full text

PDF
943

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeliovich D., Lavon I. P., Lerer I., Cohen T., Springer C., Avital A., Cutting G. R. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet. 1992 Nov;51(5):951–956. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. P., Gregory R. J., Thompson S., Souza D. W., Paul S., Mulligan R. C., Smith A. E., Welsh M. J. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 1991 Jul 12;253(5016):202–205. doi: 10.1126/science.1712984. [DOI] [PubMed] [Google Scholar]
  3. Anguiano A., Oates R. D., Amos J. A., Dean M., Gerrard B., Stewart C., Maher T. A., White M. B., Milunsky A. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA. 1992 Apr 1;267(13):1794–1797. [PubMed] [Google Scholar]
  4. Barasch J., Kiss B., Prince A., Saiman L., Gruenert D., al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature. 1991 Jul 4;352(6330):70–73. doi: 10.1038/352070a0. [DOI] [PubMed] [Google Scholar]
  5. Bear C. E., Li C. H., Kartner N., Bridges R. J., Jensen T. J., Ramjeesingh M., Riordan J. R. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992 Feb 21;68(4):809–818. doi: 10.1016/0092-8674(92)90155-6. [DOI] [PubMed] [Google Scholar]
  6. Beaudet A. L. Carrier screening for cystic fibrosis. Am J Hum Genet. 1990 Oct;47(4):603–605. [PMC free article] [PubMed] [Google Scholar]
  7. Beaudet A., Bowcock A., Buchwald M., Cavalli-Sforza L., Farrall M., King M. C., Klinger K., Lalouel J. M., Lathrop G., Naylor S. Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. Am J Hum Genet. 1986 Dec;39(6):681–693. [PMC free article] [PubMed] [Google Scholar]
  8. Biesecker L., Bowles-Biesecker B., Collins F., Kaback M., Wilfond B. General population screening for cystic fibrosis is premature. Am J Hum Genet. 1992 Feb;50(2):438–439. [PMC free article] [PubMed] [Google Scholar]
  9. Billings P. R., Kohn M. A., de Cuevas M., Beckwith J., Alper J. S., Natowicz M. R. Discrimination as a consequence of genetic testing. Am J Hum Genet. 1992 Mar;50(3):476–482. [PMC free article] [PubMed] [Google Scholar]
  10. Botkin J. R., Alemagno S. Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women. Am J Public Health. 1992 May;82(5):723–725. doi: 10.2105/ajph.82.5.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bradbury N. A., Jilling T., Berta G., Sorscher E. J., Bridges R. J., Kirk K. L. Regulation of plasma membrane recycling by CFTR. Science. 1992 Apr 24;256(5056):530–532. doi: 10.1126/science.1373908. [DOI] [PubMed] [Google Scholar]
  12. Caskey C. T., Kaback M. M., Beaudet A. L. The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet. 1990 Feb;46(2):393–393. [PMC free article] [PubMed] [Google Scholar]
  13. Chehab F. F., Wall J. Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening. Hum Genet. 1992 May;89(2):163–168. doi: 10.1007/BF00217117. [DOI] [PubMed] [Google Scholar]
  14. Cobb E., Holloway S., Elton R., Raeburn J. A. What do young people think about screening for cystic fibrosis? J Med Genet. 1991 May;28(5):322–324. doi: 10.1136/jmg.28.5.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Collins F. S. Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992 May 8;256(5058):774–779. doi: 10.1126/science.1375392. [DOI] [PubMed] [Google Scholar]
  16. Colten H. R. Screening for cystic fibrosis; public policy and personal choices. N Engl J Med. 1990 Feb 1;322(5):328–329. doi: 10.1056/NEJM199002013220510. [DOI] [PubMed] [Google Scholar]
  17. Cutting G. R., Antonarakis S. E., Buetow K. H., Kasch L. M., Rosenstein B. J., Kazazian H. H., Jr Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene. Am J Hum Genet. 1989 Mar;44(3):307–318. [PMC free article] [PubMed] [Google Scholar]
  18. Cutting G. R., Curristin S. M., Nash E., Rosenstein B. J., Lerer I., Abeliovich D., Hill A., Graham C. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet. 1992 Jun;50(6):1185–1194. [PMC free article] [PubMed] [Google Scholar]
  19. Cutting G. R., Kasch L. M., Rosenstein B. J., Tsui L. C., Kazazian H. H., Jr, Antonarakis S. E. Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med. 1990 Dec 13;323(24):1685–1689. doi: 10.1056/NEJM199012133232407. [DOI] [PubMed] [Google Scholar]
  20. Decruyenaere M., Evers-Kiebooms G., Denayer L., Van den Berghe H. Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis. Clin Genet. 1992 Apr;41(4):189–196. doi: 10.1111/j.1399-0004.1992.tb03661.x. [DOI] [PubMed] [Google Scholar]
  21. Dumur V., Lafitte J. J., Gervais R., Debaecker D., Kesteloot M., Lalau G., Roussel P. Abnormal distribution of cystic fibrosis delta F508 allele in adults with chronic bronchial hypersecretion. Lancet. 1990 Jun 2;335(8701):1340–1340. doi: 10.1016/0140-6736(90)91216-w. [DOI] [PubMed] [Google Scholar]
  22. Ferrie R. M., Schwarz M. J., Robertson N. H., Vaudin S., Super M., Malone G., Little S. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet. 1992 Aug;51(2):251–262. [PMC free article] [PubMed] [Google Scholar]
  23. Férec C., Audrezet M. P., Mercier B., Guillermit H., Moullier P., Quere I., Verlingue C. Detection of over 98% cystic fibrosis mutations in a Celtic population. Nat Genet. 1992 Jun;1(3):188–191. doi: 10.1038/ng0692-188. [DOI] [PubMed] [Google Scholar]
  24. Gasparini P., Bonizzato A., Dognini M., Pignatti P. F. Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations. Mol Cell Probes. 1992 Feb;6(1):1–7. doi: 10.1016/0890-8508(92)90064-5. [DOI] [PubMed] [Google Scholar]
  25. Green J. M. Principles and practicalities of carrier screening: attitudes of recent parents. J Med Genet. 1992 May;29(5):313–319. doi: 10.1136/jmg.29.5.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hammond K. B., Abman S. H., Sokol R. J., Accurso F. J. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med. 1991 Sep 12;325(11):769–774. doi: 10.1056/NEJM199109123251104. [DOI] [PubMed] [Google Scholar]
  27. Hamosh A., King T. M., Rosenstein B. J., Corey M., Levison H., Durie P., Tsui L. C., McIntosh I., Keston M., Brock D. J. Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet. 1992 Aug;51(2):245–250. [PMC free article] [PubMed] [Google Scholar]
  28. Holtzman N. A., Rothstein M. A. Eugenics and genetic discrimination. Am J Hum Genet. 1992 Mar;50(3):457–459. [PMC free article] [PubMed] [Google Scholar]
  29. Holtzman N. A. What drives neonatal screening programs? N Engl J Med. 1991 Sep 12;325(11):802–804. doi: 10.1056/NEJM199109123251109. [DOI] [PubMed] [Google Scholar]
  30. Hubbard R. C., McElvaney N. G., Birrer P., Shak S., Robinson W. W., Jolley C., Wu M., Chernick M. S., Crystal R. G. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med. 1992 Mar 19;326(12):812–815. doi: 10.1056/NEJM199203193261207. [DOI] [PubMed] [Google Scholar]
  31. Jorde L. B., Lathrop G. M. A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers. Am J Hum Genet. 1988 Jun;42(6):808–815. [PMC free article] [PubMed] [Google Scholar]
  32. Kaplan F., Clow C., Scriver C. R. Cystic fibrosis carrier screening by DNA analysis: a pilot study of attitudes among participants. Am J Hum Genet. 1991 Jul;49(1):240–242. [PMC free article] [PubMed] [Google Scholar]
  33. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  34. Kerem E., Corey M., Kerem B. S., Rommens J., Markiewicz D., Levison H., Tsui L. C., Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990 Nov 29;323(22):1517–1522. doi: 10.1056/NEJM199011293232203. [DOI] [PubMed] [Google Scholar]
  35. Knowles M. R., Church N. L., Waltner W. E., Yankaskas J. R., Gilligan P., King M., Edwards L. J., Helms R. W., Boucher R. C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med. 1990 Apr 26;322(17):1189–1194. doi: 10.1056/NEJM199004263221704. [DOI] [PubMed] [Google Scholar]
  36. Knowles M. R., Clarke L. L., Boucher R. C. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med. 1991 Aug 22;325(8):533–538. doi: 10.1056/NEJM199108223250802. [DOI] [PubMed] [Google Scholar]
  37. Knowles M. R., Stutts M. J., Spock A., Fischer N., Gatzy J. T., Boucher R. C. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science. 1983 Sep 9;221(4615):1067–1070. doi: 10.1126/science.6308769. [DOI] [PubMed] [Google Scholar]
  38. Kobayashi K., Knowles M. R., Boucher R. C., O'Brien W. E., Beaudet A. L. Benign missense variations in the cystic fibrosis gene. Am J Hum Genet. 1990 Oct;47(4):611–615. [PMC free article] [PubMed] [Google Scholar]
  39. Kristidis P., Bozon D., Corey M., Markiewicz D., Rommens J., Tsui L. C., Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet. 1992 Jun;50(6):1178–1184. [PMC free article] [PubMed] [Google Scholar]
  40. Lemna W. K., Feldman G. L., Kerem B., Fernbach S. D., Zevkovich E. P., O'Brien W. E., Riordan J. R., Collins F. S., Tsui L. C., Beaudet A. L. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med. 1990 Feb 1;322(5):291–296. doi: 10.1056/NEJM199002013220503. [DOI] [PubMed] [Google Scholar]
  41. Marteau T. M., van Duijn M., Ellis I. Effects of genetic screening on perceptions of health: a pilot study. J Med Genet. 1992 Jan;29(1):24–26. doi: 10.1136/jmg.29.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. McElvaney N. G., Hubbard R. C., Birrer P., Chernick M. S., Caplan D. B., Frank M. M., Crystal R. G. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet. 1991 Feb 16;337(8738):392–394. doi: 10.1016/0140-6736(91)91167-s. [DOI] [PubMed] [Google Scholar]
  43. Meindl R. S. Hypothesis: a selective advantage for cystic fibrosis heterozygotes. Am J Phys Anthropol. 1987 Sep;74(1):39–45. doi: 10.1002/ajpa.1330740104. [DOI] [PubMed] [Google Scholar]
  44. Mennie M. E., Gilfillan A., Compton M., Curtis L., Liston W. A., Pullen I., Whyte D. A., Brock D. J. Prenatal screening for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):214–216. doi: 10.1016/0140-6736(92)90476-j. [DOI] [PubMed] [Google Scholar]
  45. Miller S. R., Schwartz R. H. Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis. Am J Public Health. 1992 Feb;82(2):236–242. doi: 10.2105/ajph.82.2.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Modell B. Cystic fibrosis screening and community genetics. J Med Genet. 1990 Aug;27(8):475–479. doi: 10.1136/jmg.27.8.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Quinton P. M. Chloride impermeability in cystic fibrosis. Nature. 1983 Feb 3;301(5899):421–422. doi: 10.1038/301421a0. [DOI] [PubMed] [Google Scholar]
  48. Rigot J. M., Lafitte J. J., Dumur V., Gervais R., Manouvrier S., Biserte J., Mazeman E., Roussel P. Cystic fibrosis and congenital absence of the vas deferens. N Engl J Med. 1991 Jul 4;325(1):64–65. doi: 10.1056/NEJM199107043250116. [DOI] [PubMed] [Google Scholar]
  49. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  50. Rock M. J., Mischler E. H., Farrell P. M., Wei L. J., Bruns W. T., Hassemer D. J., Laessig R. H. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics. 1990 Jun;85(6):1001–1007. [PubMed] [Google Scholar]
  51. Romeo G., Bianco M., Devoto M., Menozzi P., Mastella G., Giunta A. M., Micalizzi C., Antonelli M., Battistini A., Santamaria F. Incidence in Italy, genetic heterogeneity, and segregation analysis of cystic fibrosis. Am J Hum Genet. 1985 Mar;37(2):338–349. [PMC free article] [PubMed] [Google Scholar]
  52. Romeo G., Devoto M., Galietta L. J. Why is the cystic fibrosis gene so frequent? Hum Genet. 1989 Dec;84(1):1–5. doi: 10.1007/BF00210660. [DOI] [PubMed] [Google Scholar]
  53. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  54. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992 Jan 10;68(1):143–155. doi: 10.1016/0092-8674(92)90213-v. [DOI] [PubMed] [Google Scholar]
  55. Rozen R., De Braekeleer M., Daigneault J., Ferreira-Rajabi L., Gerdes M., Lamoureux L., Aubin G., Simard F., Fujiwara T. M., Morgan K. Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis. Am J Med Genet. 1992 Feb 1;42(3):360–364. doi: 10.1002/ajmg.1320420322. [DOI] [PubMed] [Google Scholar]
  56. Santamaria F., Salvatore D., Castiglione O., Raia V., de Ritis G., Sebastio G. Lung involvement, the delta F508 mutation and DNA haplotype analysis in cystic fibrosis. Hum Genet. 1992 Mar;88(6):639–641. doi: 10.1007/BF02265288. [DOI] [PubMed] [Google Scholar]
  57. Scriver C. R., Bardanis M., Cartier L., Clow C. L., Lancaster G. A., Ostrowsky J. T. Beta-thalassemia disease prevention: genetic medicine applied. Am J Hum Genet. 1984 Sep;36(5):1024–1038. [PMC free article] [PubMed] [Google Scholar]
  58. Scriver C. R. Public and private views of identity: acceptance of the 1990 Ross Award. Clin Invest Med. 1991 Apr;14(2):167–175. [PubMed] [Google Scholar]
  59. Shepherd S. L., Hovell M. F., Harwood I. R., Granger L. E., Hofstetter C. R., Molgaard C., Kaplan R. M. A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers. Chest. 1990 Jun;97(6):1310–1316. doi: 10.1378/chest.97.6.1310. [DOI] [PubMed] [Google Scholar]
  60. Shoshani T., Augarten A., Gazit E., Bashan N., Yahav Y., Rivlin Y., Tal A., Seret H., Yaar L., Kerem E. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet. 1992 Jan;50(1):222–228. [PMC free article] [PubMed] [Google Scholar]
  61. Shrimpton A. E., McIntosh I., Brock D. J. The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling. J Med Genet. 1991 May;28(5):317–321. doi: 10.1136/jmg.28.5.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Ten Kate L. P., Tijmstra T. Community attitudes to cystic fibrosis carrier screening. Prenat Diagn. 1990 Apr;10(4):275–276. doi: 10.1002/pd.1970100413. [DOI] [PubMed] [Google Scholar]
  63. Trezise A. E., Buchwald M. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature. 1991 Oct 3;353(6343):434–437. doi: 10.1038/353434a0. [DOI] [PubMed] [Google Scholar]
  64. Tsui L. C., Buchwald M. No evidence for genetic heterogeneity in cystic fibrosis. Am J Hum Genet. 1988 Jan;42(1):184–184. [PMC free article] [PubMed] [Google Scholar]
  65. Tsui L. C. Tracing the mutations in cystic fibrosis by means of closely linked DNA markers. Am J Hum Genet. 1989 Mar;44(3):303–306. [PMC free article] [PubMed] [Google Scholar]
  66. Turner G., Wilcken B., Griffiths H. Cystic fibrosis screening and community genetics. J Med Genet. 1991 Aug;28(8):575–575. doi: 10.1136/jmg.28.8.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Waters D. L., Dorney S. F., Gaskin K. J., Gruca M. A., O'Halloran M., Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med. 1990 Feb 1;322(5):303–308. doi: 10.1056/NEJM199002013220505. [DOI] [PubMed] [Google Scholar]
  68. Watson E. K., Marchant J., Bush A., Williamson B. Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic. J Med Genet. 1992 Jul;29(7):490–491. [PMC free article] [PubMed] [Google Scholar]
  69. Watson E. K., Mayall E., Chapple J., Dalziel M., Harrington K., Williams C., Williamson R. Screening for carriers of cystic fibrosis through primary health care services. BMJ. 1991 Aug 31;303(6801):504–507. doi: 10.1136/bmj.303.6801.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Welsh M. J., Anderson M. P., Rich D. P., Berger H. A., Denning G. M., Ostedgaard L. S., Sheppard D. N., Cheng S. H., Gregory R. J., Smith A. E. Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation. Neuron. 1992 May;8(5):821–829. doi: 10.1016/0896-6273(92)90196-k. [DOI] [PubMed] [Google Scholar]
  71. Wertz D. C., Rosenfield J. M., Janes S. R., Erbe R. W. Attitudes toward abortion among parents of children with cystic fibrosis. Am J Public Health. 1991 Aug;81(8):992–996. doi: 10.2105/ajph.81.8.992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Wilfond Benjamin S., Fost Norman. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA. 1990 May 23;263(10):2777–2783. [PubMed] [Google Scholar]
  73. Wine J. J. No CFTR: are CF symptoms milder? Nat Genet. 1992 Apr;1(1):10–10. doi: 10.1038/ng0492-10. [DOI] [PubMed] [Google Scholar]
  74. Zeesman S., Clow C. L., Cartier L., Scriver C. R. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet. 1984 Aug;18(4):769–778. doi: 10.1002/ajmg.1320180424. [DOI] [PubMed] [Google Scholar]
  75. ten Kate L. P. Carrier screening in CF. Nature. 1989 Nov 9;342(6246):131–131. doi: 10.1038/342131a0. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES